ALIT vs YB

The Advanced Deterministic Scorecard reveals a critically weak financial health with a Piotroski F-Score of just 2/9, indicating severe operational and profitability concerns. Despite a low Price/Book of 0.39 and a forward P/E of 2.56 suggesting deep value, the company is unprofitable with a staggering -94.23% profit margin and negative ROE of -66.86%. Revenue is declining YoY by 4%, and while recent EPS growth shows a sharp +185.7% YoY increase, this is from a negative base and inconsistent with long-term trends. The stock trades at a steep discount to the $5.07 analyst target, but fundamental deterioration, poor earnings execution (0/4 beats in last 4 quarters), and lack of Altman Z-Score data raise serious sustainability concerns.

YB exhibits a stable financial profile with a Piotroski F-Score of 6/9 and an exceptionally clean balance sheet featuring zero debt. The stock is severely undervalued, trading at $17.35, which is significantly below both its Graham Number ($31.22) and its growth-based Intrinsic Value ($118.59). While technical trends are currently bearish and insider sentiment is weak, the combination of a 4.32 P/E ratio, 96% gross margins, and 30%+ growth rates presents a compelling deep-value opportunity.